Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Eldon Biologicals A/S
A/S
Active
CVR 26747007
Sandtoften 10, 2820
Gentofte
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2002 · 23 years old
16 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Eldon Biologicals A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
25M
19M
12M
6M
0M
2021: 20M
20M
2021
2022: 16M (-20% vs 2021)
16M
-20%
2022
2023: 12M (-25% vs 2022)
12M
-25%
2023
2024: 15M (+25% vs 2023)
15M
+25%
2024
2025: 14M (-7% vs 2024)
14M
-7%
2025
EBITDA
DKK millions
14M
10M
7M
3M
0M
2021: 11M
11M
2021
2022: 10M (-9% vs 2021)
10M
-9%
2022
2023: 7M (-30% vs 2022)
7M
-30%
2023
2024: 7M (0% vs 2023)
7M
0%
2024
2025: 5M (-29% vs 2024)
5M
-29%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
13.635
14.865
12.307
16.383
19.531
Staff expenses
-8.942
-7.407
-5.556
-6.163
-8.032
EBITDA
4.693
7.442
6.752
10.219
11.499
Depreciation & amort.
-72
-353
-405
-391
-404
EBIT
4.621
7.090
6.346
9.828
11.095
Net financials
402
1.413
507
-3.640
474
Profit before tax
5.024
8.503
6.853
6.188
11.569
Tax
1.123
1.829
1.491
1.216
2.471
Net profit
3.900
6.674
5.363
4.972
9.098
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
47.875
46.713
39.588
35.482
32.347
Equity
42.056
40.156
34.482
29.619
25.147
Long-term debt
1.431
340
0
0
0
Short-term debt
3.596
5.524
4.944
5.722
7.051
Total debt
5.026
5.864
4.944
5.722
7.051
Financial ratios
5-year trend
EBITDA margin (of gross profit)
34,4 %
This company
2021
2025
Equity ratio
87,8 %
This company
38,2 %
Market median
This company
Market median
130% above market
2021
2025
Return on equity
9,3 %
This company
18,4 %
Market median
This company
Market median
49% below market
2021
2025
Net profit margin (of gross profit)
28,6 %
This company
2021
2025
Asset turnover (of gross profit)
0,28×
This company
2021
2025
Debt / equity
0,14×
This company
0,62×
Market median
This company
Market median
77% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
More on Eldon Biologicals A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
